|
Market Closed -
Nasdaq
23:00:00 18/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 3.110 USD | +0.97% |
|
-11.40% | +130.37% |
| 09-16 | William Blair Initiates Zentalis Pharmaceuticals at Outperform | MT |
| 09-14 | Zentalis Pharmaceuticals, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 02:35 PM |
| Market Cap | 294M 257M 242M 220M 412M 28.25B 414M 2.9B 1.12B 14.36B 1.11B 1.08B 46.22B | P/E 2026 * |
-1.44x | P/E 2027 * | -1.62x |
|---|---|---|---|---|---|
| Enterprise Value | 89.88M 78.38M 74M 67.2M 126M 8.62B 126M 886M 342M 4.38B 338M 330M 14.11B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 10.4x |
| Free-Float |
78.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ZNTL | Delayed | |
CBOE
| ZNTL | Real-time |
Last Transcript: Zentalis Pharmaceuticals, Inc.
| 1 day | +0.97% | ||
| 1 week | -11.40% | ||
| Current month | -17.29% | ||
| 1 month | -18.59% | ||
| 3 months | -15.95% | ||
| 6 months | +21.48% | ||
| Current year | +130.37% |
| 1 week | 2.99 |  | 3.57 |
| 1 month | 2.99 | | 4.19 |
| Current year | 1.32 | | 6.95 |
| 1 year | 1.21 | | 6.95 |
| 3 years | 1.01 | | 22.7 |
| 5 years | 1.01 | | 87.19 |
| 10 years | 1.01 | | 87.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 62 | 13/11/2024 |
| Director of Finance/CFO | - | 13/11/2024 | |
Ingmar Bruns
CTO | Chief Tech/Sci/R&D Officer | 51 | 13/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
David Johnson
CHM | Chairman | 61 | 16/05/2022 |
Enoch Kariuki
BRD | Director/Board Member | 44 | 09/02/2021 |
Jan Skvarka
BRD | Director/Board Member | 59 | 12/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/14/26 A | Buy | 4,335,000 | 4.5791% | |||
| 5/26/26 A | Free | Director | 114,200 | 0.1604% | ||
| 2/6/26 A | Sell | Chief Technology Officer | 3,297 | 0.0046% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.97% | -11.40% | +104.61% | -85.97% | 294M | |
| -0.31% | +5.79% | +47.13% | +99.00% | 70.88B | |
| +0.39% | +2.06% | +39.38% | +78.27% | 62.49B | |
| +0.50% | +7.13% | +33.27% | +16.01% | 26.34B | |
| -3.21% | -7.27% | -17.10% | +356.10% | 26.21B | |
| -2.64% | -0.69% | -0.17% | -13.01% | 24.13B | |
| +0.71% | +8.03% | +25.03% | -12.74% | 20.72B | |
| -1.26% | -7.81% | +156.15% | +320.43% | 15.36B | |
| -0.22% | +3.99% | +45.54% | +172.46% | 14.46B | |
| +0.73% | +1.71% | -5.51% | +849.47% | 14.24B | |
| Average | -0.43% | +0.34% | +42.83% | +178.00% | 27.51B | |
| Weighted average by Cap. | -0.47% | +1.43% | +35.45% | +147.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 14.89M 12.98M 12.26M 11.13M 20.86M 1.43B 20.94M 147M 56.67M 726M 55.93M 54.69M 2.34B |
| Net income | -164M -143M -135M -123M -230M -15.76B -231M -1.62B -625M -8.01B -617M -603M -25.78B | -171M -149M -141M -128M -239M -16.38B -240M -1.68B -650M -8.33B -641M -627M -26.79B |
| Net Debt | -205M -178M -168M -153M -287M -19.63B -288M -2.02B -779M -9.98B -768M -751M -32.11B | -139M -122M -115M -104M -195M -13.38B -196M -1.38B -531M -6.8B -524M -512M -21.89B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | $3.110 | +0.97% | 1,259,913 |
| 17/09/26 | $3.080 | -0.65% | 1,090,672 |
| 16/09/26 | $3.100 | -0.96% | 1,225,871 |
| 15/09/26 | $3.130 | -10.57% | 1,398,707 |
| 14/09/26 | $3.500 | -0.28% | 750,363 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZNTL Stock
Select your edition
All financial news and data tailored to specific country editions
